242 related articles for article (PubMed ID: 21574647)
1. Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.
Improta G; Zupa A; Fillmore H; Deng J; Aieta M; Musto P; Liotta LA; Broaddus W; Petricoin EF; Wulfkuhle JD
J Proteome Res; 2011 Jul; 10(7):3089-97. PubMed ID: 21574647
[TBL] [Abstract][Full Text] [Related]
2. A pilot characterization of human lung NSCLC by protein pathway activation mapping.
Zupa A; Improta G; Silvestri A; Pin E; Deng J; Aieta M; Musto P; Nitti D; Mammano E; Liotta L; Belluco C; Wulfkuhle J; Petricoin E
J Thorac Oncol; 2012 Dec; 7(12):1755-1766. PubMed ID: 23154546
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.
Ummanni R; Mannsperger HA; Sonntag J; Oswald M; Sharma AK; König R; Korf U
Biochim Biophys Acta; 2014 May; 1844(5):950-9. PubMed ID: 24361481
[TBL] [Abstract][Full Text] [Related]
4. Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type.
VanMeter AJ; Rodriguez AS; Bowman ED; Jen J; Harris CC; Deng J; Calvert VS; Silvestri A; Fredolini C; Chandhoke V; Petricoin EF; Liotta LA; Espina V
Mol Cell Proteomics; 2008 Oct; 7(10):1902-24. PubMed ID: 18687633
[TBL] [Abstract][Full Text] [Related]
5. Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors.
Baldelli E; Bellezza G; Haura EB; Crinó L; Cress WD; Deng J; Ludovini V; Sidoni A; Schabath MB; Puma F; Vannucci J; Siggillino A; Liotta LA; Petricoin EF; Pierobon M
Oncotarget; 2015 Oct; 6(32):32368-79. PubMed ID: 26468985
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the tumor immune-microenvironment of primary and brain metastases of non-small-cell lung cancer reveals organ-specific and EGFR mutation-dependent unique immune landscape.
Song SG; Kim S; Koh J; Yim J; Han B; Kim YA; Jeon YK; Chung DH
Cancer Immunol Immunother; 2021 Jul; 70(7):2035-2048. PubMed ID: 33420630
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
[TBL] [Abstract][Full Text] [Related]
8. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
[TBL] [Abstract][Full Text] [Related]
9. Predicting the sites of metastases from lung cancer using molecular biologic markers.
D'Amico TA; Aloia TA; Moore MB; Conlon DH; Herndon JE; Kinch MS; Harpole DH
Ann Thorac Surg; 2001 Oct; 72(4):1144-8. PubMed ID: 11603427
[TBL] [Abstract][Full Text] [Related]
10. Steroid receptor and growth factor receptor expression in human nonsmall cell lung cancers using cells procured by laser-capture microdissection.
Kerr A; Eliason JF; Wittliff JL
Adv Exp Med Biol; 2008; 617():377-84. PubMed ID: 18497061
[TBL] [Abstract][Full Text] [Related]
11. PPARGC1A is upregulated and facilitates lung cancer metastasis.
Li JD; Feng QC; Qi Y; Cui G; Zhao S
Exp Cell Res; 2017 Oct; 359(2):356-360. PubMed ID: 28803067
[TBL] [Abstract][Full Text] [Related]
12. Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicine.
Baldelli E; Haura EB; Crinò L; Cress DW; Ludovini V; Schabath MB; Liotta LA; Petricoin EF; Pierobon M
Proteomics Clin Appl; 2015 Oct; 9(9-10):928-37. PubMed ID: 25676683
[TBL] [Abstract][Full Text] [Related]
13. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.
Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A
Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950
[TBL] [Abstract][Full Text] [Related]
14. [Basis of Tumor Microenvironment Relevant to Immunotherapies for Brain Metastases of NSCLC].
Lan Q; Ji C; Yao Y
Zhongguo Fei Ai Za Zhi; 2019 Aug; 22(8):512-519. PubMed ID: 31451142
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays.
Cowherd SM; Espina VA; Petricoin EF; Liotta LA
Clin Breast Cancer; 2004 Dec; 5(5):385-92. PubMed ID: 15585078
[TBL] [Abstract][Full Text] [Related]
16. A specific gene expression signature for visceral organ metastasis in breast cancer.
Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
[TBL] [Abstract][Full Text] [Related]
17. The genomic landscape of breast cancer brain metastases: a systematic review.
Morgan AJ; Giannoudis A; Palmieri C
Lancet Oncol; 2021 Jan; 22(1):e7-e17. PubMed ID: 33387511
[TBL] [Abstract][Full Text] [Related]
18. Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy.
Wulfkuhle JD; Speer R; Pierobon M; Laird J; Espina V; Deng J; Mammano E; Yang SX; Swain SM; Nitti D; Esserman LJ; Belluco C; Liotta LA; Petricoin EF
J Proteome Res; 2008 Apr; 7(4):1508-17. PubMed ID: 18257519
[TBL] [Abstract][Full Text] [Related]
19. An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer.
Tsakonas G; Lewensohn R; Botling J; Ortiz-Villalon C; Micke P; Friesland S; Nord H; Lindskog M; Sandelin M; Hydbring P; Ekman S
Eur J Cancer; 2020 Jun; 132():24-34. PubMed ID: 32325417
[TBL] [Abstract][Full Text] [Related]
20. BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR
Yin W; Zhao Y; Kang X; Zhao P; Fu X; Mo X; Wang Y; Huang Y
Theranostics; 2020; 10(14):6122-6135. PubMed ID: 32483443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
